Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Subscribe to EMJ GOLD
Subscribe to EMJ
3
Mins
5th December 2023
The Hallmarks of Cancer in 2023
CURRENT cancer hallmarks, their capabilities, and potential targeted therapies were the focus of the presentation given by Douglas Hanahan…
1
Mins
5th December 2023
Precision Medicine-Based Platform to Guide the Treatment of
EML4-ALK
Lung Cancers and Other Non-Small Cell Lung Cancers
Lung cancer (LC) remains the top cause of cancer-associated mortality worldwide, with a 10-year overall survival rate of only 5%.1…
3
Mins
5th December 2023
Isolated Tumour Cells in Early Endometrial Carcinomas
Endometrial cancer is the most common gynaecologic malignancy in high-income countries due to increased life expectancy. Approximately…
1
Mins
5th December 2023
Programmed Death-Ligand 1 Expression and its Relation to
EML4-ALK
Gene Variants in Metastatic Lung Adenocarcinoma: A Single Centre Real-World Experience
Targeted therapy and immunotherapy have revolutionised the treatment of metastatic non-small cell lung cancer, particularly adenocarcinoma…
6
Mins
5th December 2023
ESMO 2023 Abstract Highlights
FOR the first time, there is an alternative to chemotherapy for patients with advanced or metastatic urothelial carcinoma. The results of a…
15
Mins
5th December 2023
Improving Inclusivity and Diversity in Clinical Trials
Although clinical trials form the backbone of evidence-based medicine, cohorts participating in clinical trials are often poorly…
6
Mins
5th December 2023
Dostarlimab and Radiotherapy in A Patient with MSI-H/dMMR Endometrial Cancer
Endometrial carcinoma (EC) is the world’s most common gynaecological malignancy, with a global incidence of 382,069 new cases and 89,929…
Spotlight: November 2023
GOLD looks back at some of the top pharma news stories of the past month including new appointments, regulatory wins and surprising survey results.
4th December 2023
Paediatric and Adult Atopic dermatitis
In this podcast, Professor Anthony Bewley, Consultant Dermatologist at Barts Health, discusses paediatric and adult atopic dermatitis.
1
Mins
4th December 2023
Impact of In-House PCR Testing for
Candida auris
on Hospital-Onset Cases
Testing for Candida auris on patient admission helped to identify more cases, and reduced the number of hospital-onset cases, according to a new study. Read more.
←
1
2
3
…
133
134
135
136
137
138
139
…
866
867
868
→